Construction and Application of a Systematic Nursing Program for Enhanced Recovery after Surgery in the Perioperative Period of Laparoscopic Radical Resection for Gastrointestinal Tumors

Abstract To construct a systematic nursing program for enhanced recovery after surgery (ERAS) in the perioperative period of laparoscopic radical resection for gastrointestinal tumors and analyze its effectiveness. Methods Based on the concept of enhanced recovery after surgery (ERAS), a systematic nursing program for enhanced recovery in the perioperative period of patients undergoing laparoscopic radical resection for gastrointestinal tumors was constructed. A total of 100 patients who underwent laparoscopic radical resection for gastrointestinal tumors at the Zengcheng Branch of Nanfang Hospital, Southern Medical University from October 2025 to September 2026 were selected. They were divided into a control group (receiving routine ERAS nursing) and an experimental group (receiving systematic nursing for enhanced recovery in the perioperative period) according to the admission time, with 50 cases in each group. Gastrointestinal function recovery, quality of recovery, pain, and complications were compared between the two groups. Results The first flatus, defecation, and eating times of the experimental group were earlier than those of the control group (P < 0.05). After the intervention, the scores of the 40-item Quality of Recovery Questionnaire (QoR-40) in both groups increased, and the score of the experimental group was higher (P < 0.05). The Visual Analogue Scale (VAS) scores of the experimental group at different postoperative times were all lower than those of the control group (P < 0.05); the incidence of complications was lower than that of the control group (P < 0.05). Conclusion The systematic nursing program for enhanced recovery in the perioperative period is scientific and feasible. It can promote the recovery of gastrointestinal function, relieve pain, reduce complications, and is suitable for clinical promotion. Trial registration: Medical Research Registration and Filing Information System, MR-44-26-006102, registered on 20 January 2026.